Programmatic review for prostate cancer research program (pcrp) for congressionally directed medical research programs (cdmrp).

Active Awarded Last action

Contract number
HT942726FE073
Awardee
Awarding agency
Obligated
$187,702

Award facts

Contract value 54% obligated
$349,802.68 Current and potential, with all options
Completion date 31% complete
Current and potential, with all options
Contracting staff
NAICS code
541990 All Other Professional, Scientific, and Technical Services
PSC
R408 Support- Professional: Program Management/Support
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Cost Plus Fixed Fee
Place of performance
Frederick, MD 21703, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency issued a delivery order to Leidos, Inc. on July 1, 2026, with a ceiling value of $349,802.68 for programmatic review support to the Prostate Cancer Research Program under the Congressionally Directed Medical Research Programs.

Place of performance is Frederick, Maryland. The order runs through June 30, 2027, and is priced on a cost-plus-fixed-fee basis. No set-aside applies to this delivery order.

Quick answers

Who was awarded contract HT942726FE073?

HT942726FE073 was awarded to Leidos, Inc. by Defense Health Agency (Department of Defense) on July 1, 2026.

How much is contract HT942726FE073 worth?

The government has obligated $187,702 on HT942726FE073. Its current value, with exercised options, is $349,803.

Is contract HT942726FE073 an order under another contract?

Yes. HT942726FE073 is a delivery order under HT942523D0002, an indefinite delivery contract.

Was contract HT942726FE073 competed?

The extent of competition for HT942726FE073 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award